Item 1.01 Entry Into A Materially Defiitive Agreement.

On November 8, 2022, we signed a settlement and coexistence agreement with Endo Pharmaceuticals, Inc., a Delaware corporation ("Endo"). Endo objected to our use of the Endo Brands and Endo Drops brands ("Endo Brands") based on their ownership of various trademarks with "endo" in them (the "Endo Marks"). We agreed to (i) neither use nor apply to register the Endo Brands in connection with prescription or over-the-counter pharmaceutical preparations or pharmaceutical goods that require a prescription, and (ii) not apply for "endo" on its own as a trademark. Endo agreed not to object to any attempt by us to register a mark not in violation of this agreement and both parties not to use a use a brand or product with "endo" as part of its name if it is already being used by the other party.

The geographic scope of the agreement is the United States and its term is from the reporting date until Endo, or its successor or assign, expressly abandons the Endo Mark.






2

© Edgar Online, source Glimpses